Indeed, in those with impaired awareness of hypoglycemia, despite using a form of diabetes technology (isCGM/CSII or sensor-augmented pump), the use of MM780G led to both improvement of hypoglycemia awareness and HbA1c levels.25 The benefit of automated insulin delivery systems notwithstanding, access to these systems remains limited in many parts of the world. This evidence concerns the gene INS and Hypoglycemia.